Woodline Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Sell
331,620
-328,905
-50% -$24.1M 0.07% 343
2026
Q1
$50.4M Sell
660,525
-122,584
-16% -$8.84M 0.19% 137
2025
Q4
$50M Buy
783,109
+461,667
+144% +$28.5M 0.19% 131
2025
Q3
$20.3M Buy
321,442
+59,116
+23% +$4.13M 0.1% 281
2025
Q2
$19.6M Buy
262,326
+252,596
+2,596% +$19.8M 0.1% 293
2025
Q1
$857K Buy
9,730
+2,769
+40% +$261K 0.01% 779
2024
Q4
$636K Buy
+6,961
New +$714K ﹤0.01% 811

Other funds holding EMN

Woodline Partners's EMN Position: Q2 2026 in Review

Woodline Partners reduced its Eastman Chemical (EMN) stake by 50% in Q2 2026, selling an estimated $24.1M and leaving 331,620 shares worth $22.2M. The position accounts for 0.07% of the portfolio, ranked #343.

Woodline Partners first reported a position in EMN in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.4M in Q1 2026. 645 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Woodline Partners held 331,620 shares of Eastman Chemical worth $22.2M as of Q2 2026.
  • Woodline Partners sold 328,905 Eastman Chemical shares in Q2 2026, an estimated $24.1M.
  • Eastman Chemical made up 0.07% of Woodline Partners's portfolio in Q2 2026, its #343 holding.
  • Woodline Partners first reported a position in Eastman Chemical in Q4 2024 and has held it in 7 quarters since.
  • Woodline Partners's Eastman Chemical position peaked at $50.4M in Q1 2026.
  • 645 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.